The Covid-19, Epidemiology, Clinic and Prevention,Current Genomics

当前位置： X-MOL 学术 › Curr. Genomics › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

The Covid-19, Epidemiology, Clinic and Prevention
Current Genomics ( IF 2.6 ) Pub Date : 2020-07-10 , DOI: 10.2174/1389202921999200427133052
Alessandro Antonelli ₁ , Giusy Elia ₁ , Silvia Martina Ferrari ₁ , Rudy Foddis ₁ , Salvatore De Marco ₁ , Alfonso Cristaudo ₁ , Poupak Fallahi ₁

Affiliation

In December 2019, a cluster of pneumonia cases, due to a newly identified β-coronavirus, occurred in Wuhan, China (Covid-19, or SARS-CoV-2). This was a zoonotic coronavirus breakout, that allowing human-to-human transmission, raised global health concerns [1]. On 26 February 2020, the rate of new cases begin to decline in China, but the tendency changed outside China, where new cases occurred, such as in Italy, South Korea and Iran; and for the first time the number of new cases outside China surmounted those reported in China [2]. After China, Italy had the second largest number of Covid-19 casefatality rate [3]. Unfortunately, the infection spread also to all other European countries. Covid-19 is also spreading in US, mainly a high concentration in New York City, with a higher fatality rate. Other countries such as Iran, Turkey, Canada, South Korea, Brazil, Israel, have also unfortunately experienced a large spread of the infection. African countries are at particular risk because of the density of the communities and insufficient diagnostic and therapeutic capacities [4]. According to the European Centre for Disease Prevention and Control (ECDC), since December 31, 2019 and as of April 3, 2020, >1 000 000 cases of Covid-19 have been reported, including 51,515 deaths, and the number is increasing every day.

更新日期：2020-07-10

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>